Journal article · 2026 · Open access

AI in the Pharmaceutical Industry: Innovations, Applications, and Challenges

Vidya Krushna Sahare, Sangita A. Kale, Atul Anand Phatak, Nitin Khambayat

International journal of research and scientific innovation, 13(4), 2002–2023 · Published 1 January 2026 · DOI 10.51244/ijrsi.2026.1304000170

Free PDFView at the publisherCite this paper

In brief

“AI in the Pharmaceutical Industry: Innovations, Applications, and Challenges” is a 2026 journal article by Vidya Krushna Sahare and 3 co-authors, published in International journal of research and scientific innovation. OpenAlex counts 0 citations as of 15 November 2026. It is open access: the full text is free to read at International journal of research and scientific innovation.

Citations
0
References
18
Authors
4

Abstract

Artificial Intelligence (AI) is increasingly transforming the pharmaceutical industry by streamlining processes across drug discovery, clinical development, manufacturing, and post-marketing surveillance. In drug discovery, platforms such as DeepMind’s AlphaFold enable accurate protein structure prediction and identification of promising drug candidates, thereby reducing timelines and costs traditionally associated with early-stage research. Clinical trials benefit from AI-driven predictive modeling, which improves patient recruitment, optimizes trial design, and enhances real-time monitoring through wearable devices and IoT sensors, ultimately increasing efficiency and success rates. In manufacturing and supply chain management, AI supports advanced forecasting, automation, and blockchain-based traceability, reducing waste and mitigating risks of counterfeit drugs. Personalized medicine is strengthened by AI tools that analyze genomic and clinical data to generate individualized treatment plans, improving therapeutic outcomes while minimizing adverse effects. Despite these advances, challenges remain in ensuring data quality, algorithmic transparency, regulatory compliance, and ethical governance. Regulatory agencies such as the FDA and EMA emphasize the need for explainable and validated AI models before widespread adoption. This review critically evaluates the innovations and limitations of AI in the pharmaceutical sector, highlighting its potential to improve healthcare delivery while underscoring the importance of rigorous validation and regulatory oversight.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Sahare, V. K., Kale, S. A., Phatak, A. A., & Khambayat, N. (2026). AI in the Pharmaceutical Industry: Innovations, Applications, and Challenges. International journal of research and scientific innovation, 13(4), 2002–2023. https://doi.org/10.51244/ijrsi.2026.1304000170

MLA 9

Sahare, Vidya Krushna, et al. “AI in the Pharmaceutical Industry: Innovations, Applications, and Challenges.” International journal of research and scientific innovation, vol. 13, no. 4, 2026, pp. 2002–2023. https://doi.org/10.51244/ijrsi.2026.1304000170.

Chicago

Sahare, Vidya Krushna, Sangita A. Kale, Atul Anand Phatak, and Nitin Khambayat. 2026. “AI in the Pharmaceutical Industry: Innovations, Applications, and Challenges.” International journal of research and scientific innovation 13 (4): 2002–2023. https://doi.org/10.51244/ijrsi.2026.1304000170.

Harvard

Sahare, V. K. et al. (2026) ‘AI in the Pharmaceutical Industry: Innovations, Applications, and Challenges’, International journal of research and scientific innovation, 13(4), pp. 2002–2023. doi:10.51244/ijrsi.2026.1304000170.

IEEE

V. K. Sahare, S. A. Kale, A. A. Phatak, and N. Khambayat, “AI in the Pharmaceutical Industry: Innovations, Applications, and Challenges,” International journal of research and scientific innovation, vol. 13, no. 4, pp. 2002–2023, 2026, doi: 10.51244/ijrsi.2026.1304000170.

BibTeX

@article{sahare2026pharmaceutical,
  title     = {{AI in the Pharmaceutical Industry: Innovations, Applications, and Challenges}},
  author    = {Sahare, Vidya Krushna and Kale, Sangita A. and Phatak, Atul Anand and Khambayat, Nitin},
  journal   = {International journal of research and scientific innovation},
  year      = {2026},
  volume    = {13},
  number    = {4},
  pages     = {2002--2023},
  doi       = {10.51244/ijrsi.2026.1304000170},
  url       = {https://doi.org/10.51244/ijrsi.2026.1304000170}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education

  • artificial intelligence in pharmaceuticals
  • drug discovery
  • AlphaFold
  • protein structure prediction
  • clinical trial optimization
  • patient recruitment
  • pharmaceutical manufacturing
  • supply chain management

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Sahare, V. K., Kale, S. A., Phatak, A. A., & Khambayat, N. (2026). AI in the Pharmaceutical Industry: Innovations, Applications, and Challenges. International journal of research and scientific innovation, 13(4), 2002–2023. https://doi.org/10.51244/ijrsi.2026.1304000170

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at International journal of research and scientific innovation.

Who wrote this paper?

Vidya Krushna Sahare, Sangita A. Kale, Atul Anand Phatak, Nitin Khambayat.

What is the DOI of this paper?

10.51244/ijrsi.2026.1304000170. The permanent link is https://doi.org/10.51244/ijrsi.2026.1304000170.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.